Copyright Reports & Markets. All rights reserved.

Global and United States Artificial Dermal Matrix Market Report & Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Artificial Dermal Matrix Revenue in Artificial Dermal Matrix Business (2017-2022) & (US$ Million) Introduction
    • 1.2 Global Artificial Dermal Matrix Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Artificial Dermal Matrix Market Size for the Year 2017-2028
      • 1.2.2 Global Artificial Dermal Matrix Market Size for the Year 2017-2028
    • 1.3 Artificial Dermal Matrix Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.3.1 The Market Share of United States Artificial Dermal Matrix in Global, 2017 VS 2022 VS 2028
      • 1.3.2 The Growth Rate of Artificial Dermal Matrix Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.4 Artificial Dermal Matrix Market Dynamics
      • 1.4.1 Artificial Dermal Matrix Industry Trends
      • 1.4.2 Artificial Dermal Matrix Market Drivers
      • 1.4.3 Artificial Dermal Matrix Market Challenges
      • 1.4.4 Artificial Dermal Matrix Market Restraints
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Artificial Dermal Matrix by Type

    • 2.1 Artificial Dermal Matrix Market Segment by Type
      • 2.1.1 From Animal Source
      • 2.1.2 From Human Source
    • 2.2 Global Artificial Dermal Matrix Market Size by Type (2017, 2022 & 2028)
    • 2.3 Global Artificial Dermal Matrix Market Size by Type (2017-2028)
    • 2.4 United States Artificial Dermal Matrix Market Size by Type (2017, 2022 & 2028)
    • 2.5 United States Artificial Dermal Matrix Market Size by Type (2017-2028)

    3 Artificial Dermal Matrix by Application

    • 3.1 Artificial Dermal Matrix Market Segment by Application
      • 3.1.1 Hospitals
      • 3.1.2 Clinics
    • 3.2 Global Artificial Dermal Matrix Market Size by Application (2017, 2022 & 2028)
    • 3.3 Global Artificial Dermal Matrix Market Size by Application (2017-2028)
    • 3.4 United States Artificial Dermal Matrix Market Size by Application (2017, 2022 & 2028)
    • 3.5 United States Artificial Dermal Matrix Market Size by Application (2017-2028)

    4 Global Artificial Dermal Matrix Competitor Landscape by Company

    • 4.1 Global Artificial Dermal Matrix Market Size by Company
      • 4.1.1 Top Global Artificial Dermal Matrix Companies Ranked by Revenue (2021)
      • 4.1.2 Global Artificial Dermal Matrix Revenue by Player (2017-2022)
    • 4.2 Global Artificial Dermal Matrix Concentration Ratio (CR)
      • 4.2.1 Artificial Dermal Matrix Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Companies of Artificial Dermal Matrix in 2021
      • 4.2.3 Global Artificial Dermal Matrix Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Artificial Dermal Matrix Headquarters, Revenue in Artificial Dermal Matrix Business (2017-2022) & (US$ Million) Type
      • 4.3.1 Global Artificial Dermal Matrix Headquarters and Area Served
      • 4.3.2 Global Artificial Dermal Matrix Companies Revenue in Artificial Dermal Matrix Business (2017-2022) & (US$ Million) Type
      • 4.3.3 Date of International Companies Enter into Artificial Dermal Matrix Market
    • 4.4 Companies Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Artificial Dermal Matrix Market Size by Company
      • 4.5.1 Top Artificial Dermal Matrix Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Artificial Dermal Matrix Revenue by Players (2020, 2021 & 2022)

    5 Global Artificial Dermal Matrix Market Size by Region

    • 5.1 Global Artificial Dermal Matrix Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Artificial Dermal Matrix Market Size by Region (2017-2028)
      • 5.2.1 Global Artificial Dermal Matrix Market Size by Region: 2017-2022
      • 5.2.2 Global Artificial Dermal Matrix Market Size by Region (2023-2028)

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Artificial Dermal Matrix Market Size YoY Growth 2017-2028
      • 6.1.2 North America Artificial Dermal Matrix Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Artificial Dermal Matrix Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Artificial Dermal Matrix Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Southeast Asia
    • 6.3 Europe
      • 6.3.1 Europe Artificial Dermal Matrix Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Artificial Dermal Matrix Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Artificial Dermal Matrix Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Artificial Dermal Matrix Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Artificial Dermal Matrix Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Artificial Dermal Matrix Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia

    7 Company Profiles

    • 7.1 MTF Biologics
      • 7.1.1 MTF Biologics Company Details
      • 7.1.2 MTF Biologics Business Overview
      • 7.1.3 MTF Biologics Artificial Dermal Matrix Introduction
      • 7.1.4 MTF Biologics Revenue in Artificial Dermal Matrix Business (2017-2022)
      • 7.1.5 MTF Biologics Recent Development
    • 7.2 Allosource
      • 7.2.1 Allosource Company Details
      • 7.2.2 Allosource Business Overview
      • 7.2.3 Allosource Artificial Dermal Matrix Introduction
      • 7.2.4 Allosource Revenue in Artificial Dermal Matrix Business (2017-2022)
      • 7.2.5 Allosource Recent Development
    • 7.3 Parametrics Medical
      • 7.3.1 Parametrics Medical Company Details
      • 7.3.2 Parametrics Medical Business Overview
      • 7.3.3 Parametrics Medical Artificial Dermal Matrix Introduction
      • 7.3.4 Parametrics Medical Revenue in Artificial Dermal Matrix Business (2017-2022)
      • 7.3.5 Parametrics Medical Recent Development
    • 7.4 LifeNet Health
      • 7.4.1 LifeNet Health Company Details
      • 7.4.2 LifeNet Health Business Overview
      • 7.4.3 LifeNet Health Artificial Dermal Matrix Introduction
      • 7.4.4 LifeNet Health Revenue in Artificial Dermal Matrix Business (2017-2022)
      • 7.4.5 LifeNet Health Recent Development
    • 7.5 Gunze
      • 7.5.1 Gunze Company Details
      • 7.5.2 Gunze Business Overview
      • 7.5.3 Gunze Artificial Dermal Matrix Introduction
      • 7.5.4 Gunze Revenue in Artificial Dermal Matrix Business (2017-2022)
      • 7.5.5 Gunze Recent Development
    • 7.6 Tissue Regenix
      • 7.6.1 Tissue Regenix Company Details
      • 7.6.2 Tissue Regenix Business Overview
      • 7.6.3 Tissue Regenix Artificial Dermal Matrix Introduction
      • 7.6.4 Tissue Regenix Revenue in Artificial Dermal Matrix Business (2017-2022)
      • 7.6.5 Tissue Regenix Recent Development
    • 7.7 Zimmer Biomet
      • 7.7.1 Zimmer Biomet Company Details
      • 7.7.2 Zimmer Biomet Business Overview
      • 7.7.3 Zimmer Biomet Artificial Dermal Matrix Introduction
      • 7.7.4 Zimmer Biomet Revenue in Artificial Dermal Matrix Business (2017-2022)
      • 7.7.5 Zimmer Biomet Recent Development
    • 7.8 Integra LifeSciences
      • 7.8.1 Integra LifeSciences Company Details
      • 7.8.2 Integra LifeSciences Business Overview
      • 7.8.3 Integra LifeSciences Artificial Dermal Matrix Introduction
      • 7.8.4 Integra LifeSciences Revenue in Artificial Dermal Matrix Business (2017-2022)
      • 7.8.5 Integra LifeSciences Recent Development
    • 7.9 Organogenesis
      • 7.9.1 Organogenesis Company Details
      • 7.9.2 Organogenesis Business Overview
      • 7.9.3 Organogenesis Artificial Dermal Matrix Introduction
      • 7.9.4 Organogenesis Revenue in Artificial Dermal Matrix Business (2017-2022)
      • 7.9.5 Organogenesis Recent Development
    • 7.10 Flower Orthopedics
      • 7.10.1 Flower Orthopedics Company Details
      • 7.10.2 Flower Orthopedics Business Overview
      • 7.10.3 Flower Orthopedics Artificial Dermal Matrix Introduction
      • 7.10.4 Flower Orthopedics Revenue in Artificial Dermal Matrix Business (2017-2022)
      • 7.10.5 Flower Orthopedics Recent Development
    • 7.11 Promethean
      • 7.11.1 Promethean Company Details
      • 7.11.2 Promethean Business Overview
      • 7.11.3 Promethean Artificial Dermal Matrix Introduction
      • 7.11.4 Promethean Revenue in Artificial Dermal Matrix Business (2017-2022)
      • 7.11.5 Promethean Recent Development
    • 7.12 Wright Medical Group
      • 7.12.1 Wright Medical Group Company Details
      • 7.12.2 Wright Medical Group Business Overview
      • 7.12.3 Wright Medical Group Artificial Dermal Matrix Introduction
      • 7.12.4 Wright Medical Group Revenue in Artificial Dermal Matrix Business (2017-2022)
      • 7.12.5 Wright Medical Group Recent Development
    • 7.13 Aziyo Biologics
      • 7.13.1 Aziyo Biologics Company Details
      • 7.13.2 Aziyo Biologics Business Overview
      • 7.13.3 Aziyo Biologics Artificial Dermal Matrix Introduction
      • 7.13.4 Aziyo Biologics Revenue in Artificial Dermal Matrix Business (2017-2022)
      • 7.13.5 Aziyo Biologics Recent Development
    • 7.14 RTI Surgical
      • 7.14.1 RTI Surgical Company Details
      • 7.14.2 RTI Surgical Business Overview
      • 7.14.3 RTI Surgical Artificial Dermal Matrix Introduction
      • 7.14.4 RTI Surgical Revenue in Artificial Dermal Matrix Business (2017-2022)
      • 7.14.5 RTI Surgical Recent Development
    • 7.15 MiMedx Group
      • 7.15.1 MiMedx Group Company Details
      • 7.15.2 MiMedx Group Business Overview
      • 7.15.3 MiMedx Group Artificial Dermal Matrix Introduction
      • 7.15.4 MiMedx Group Revenue in Artificial Dermal Matrix Business (2017-2022)
      • 7.15.5 MiMedx Group Recent Development
    • 7.16 Tides Medical
      • 7.16.1 Tides Medical Company Details
      • 7.16.2 Tides Medical Business Overview
      • 7.16.3 Tides Medical Artificial Dermal Matrix Introduction
      • 7.16.4 Tides Medical Revenue in Artificial Dermal Matrix Business (2017-2022)
      • 7.16.5 Tides Medical Recent Development
    • 7.17 Ventris Medical
      • 7.17.1 Ventris Medical Company Details
      • 7.17.2 Ventris Medical Business Overview
      • 7.17.3 Ventris Medical Artificial Dermal Matrix Introduction
      • 7.17.4 Ventris Medical Revenue in Artificial Dermal Matrix Business (2017-2022)
      • 7.17.5 Ventris Medical Recent Development
    • 7.18 Vivex Biomedical
      • 7.18.1 Vivex Biomedical Company Details
      • 7.18.2 Vivex Biomedical Business Overview
      • 7.18.3 Vivex Biomedical Artificial Dermal Matrix Introduction
      • 7.18.4 Vivex Biomedical Revenue in Artificial Dermal Matrix Business (2017-2022)
      • 7.18.5 Vivex Biomedical Recent Development
    • 7.19 Aedicell
      • 7.19.1 Aedicell Company Details
      • 7.19.2 Aedicell Business Overview
      • 7.19.3 Aedicell Artificial Dermal Matrix Introduction
      • 7.19.4 Aedicell Revenue in Artificial Dermal Matrix Business (2017-2022)
      • 7.19.5 Aedicell Recent Development
    • 7.20 Amniox Medical
      • 7.20.1 Amniox Medical Company Details
      • 7.20.2 Amniox Medical Business Overview
      • 7.20.3 Amniox Medical Artificial Dermal Matrix Introduction
      • 7.20.4 Amniox Medical Revenue in Artificial Dermal Matrix Business (2017-2022)
      • 7.20.5 Amniox Medical Recent Development
    • 7.21 StimLabs
      • 7.21.1 StimLabs Company Details
      • 7.21.2 StimLabs Business Overview
      • 7.21.3 StimLabs Artificial Dermal Matrix Introduction
      • 7.21.4 StimLabs Revenue in Artificial Dermal Matrix Business (2017-2022)
      • 7.21.5 StimLabs Recent Development
    • 7.22 Skye Biologics
      • 7.22.1 Skye Biologics Company Details
      • 7.22.2 Skye Biologics Business Overview
      • 7.22.3 Skye Biologics Artificial Dermal Matrix Introduction
      • 7.22.4 Skye Biologics Revenue in Artificial Dermal Matrix Business (2017-2022)
      • 7.22.5 Skye Biologics Recent Development

    8 Research Findings and Conclusion

      9 Appendix

      • 9.1 Research Methodology
        • 9.1.1 Methodology/Research Approach
        • 9.1.2 Data Source
      • 9.2 Author Details

      Summary:

      Market Analysis and Insights: Global and United States Artificial Dermal Matrix Market
      This report focuses on global and United States Artificial Dermal Matrix market, also covers the segmentation data of other regions in regional level and county level.
      Due to the COVID-19 pandemic, the global Artificial Dermal Matrix market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, From Animal Source accounting for % of the Artificial Dermal Matrix global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospitals was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
      In United States the Artificial Dermal Matrix market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
      Global Artificial Dermal Matrix Scope and Market Size
      Artificial Dermal Matrix market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Artificial Dermal Matrix market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
      For United States market, this report focuses on the Artificial Dermal Matrix market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
      Segment by Type, the Artificial Dermal Matrix market is segmented into
      From Animal Source
      From Human Source
      Segment by Application, the Artificial Dermal Matrix market is segmented into
      Hospitals
      Clinics
      Regional and Country-level Analysis
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Southeast Asia
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      Competitive Landscape and Artificial Dermal Matrix Market Share Analysis
      Artificial Dermal Matrix market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Artificial Dermal Matrix business, the date to enter into the Artificial Dermal Matrix market, Revenue in Artificial Dermal Matrix Business (2017-2022) & (US$ Million) introduction, recent developments, etc.
      The major vendors covered:
      MTF Biologics
      Allosource
      Parametrics Medical
      LifeNet Health
      Gunze
      Tissue Regenix
      Zimmer Biomet
      Integra LifeSciences
      Organogenesis
      Flower Orthopedics
      Promethean
      Wright Medical Group
      Aziyo Biologics
      RTI Surgical
      MiMedx Group
      Tides Medical
      Ventris Medical
      Vivex Biomedical
      Aedicell
      Amniox Medical
      StimLabs
      Skye Biologics
      Buy now